In nasopharyngeal carcinoma, H19 promoted invasive properties via inhibition of miR-630 and the subsequent regulation of enhancer of zeste homolog 2 (EZH2), which is a target of the miRNA 26. Here, EZH2 is linked to nasopharyngeal carcinoma.